In July 2025, Tiggo Pharmaceuticals' wholly-owned subsidiary, Tiggo Japan, acquired 56.37% of the equity of MICRON Corporation in Japan for 484 million yen (approximately 23.4771 million yuan).

MICRON is a local medical imaging and clinical services company in Japan, with extensive local customer resources and industry experience. After the completion of this transaction, Taige Pharmaceutical has further expanded its business layout in Japan and the Asia Pacific region with the help of MICRON's local foundation. Both parties have achieved a deep integration of technology and talent, enhanced their comprehensive competitiveness in the fields of medical imaging and clinical services, and improved the company's global service network in the field of big health.